These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 21342185

  • 1. Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells.
    Schütz C, Hoves S, Halbritter D, Zhang HG, Mountz JD, Fleck M.
    Immunology; 2011 May; 133(1):115-22. PubMed ID: 21342185
    [Abstract] [Full Text] [Related]

  • 2. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S, Krause SW, Halbritter D, Zhang HG, Mountz JD, Schölmerich J, Fleck M.
    J Immunol; 2003 Jun 01; 170(11):5406-13. PubMed ID: 12759415
    [Abstract] [Full Text] [Related]

  • 3. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells.
    Hoves S, Krause SW, Herfarth H, Halbritter D, Zhang HG, Mountz JD, Schölmerich J, Fleck M.
    Immunobiology; 2004 Jun 01; 208(5):463-75. PubMed ID: 15124861
    [Abstract] [Full Text] [Related]

  • 4. Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections.
    Kusuhara M, Matsue H.
    Exp Dermatol; 2005 Apr 01; 14(4):273-80. PubMed ID: 15810885
    [Abstract] [Full Text] [Related]

  • 5. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
    Ukyo N, Hori T, Yanagita S, Ishikawa T, Uchiyama T.
    Immunology; 2003 Jun 01; 109(2):226-31. PubMed ID: 12757617
    [Abstract] [Full Text] [Related]

  • 6. Mouse T cells engineered to display on their surface a novel form of FasL protein undergo apoptosis when stimulated with alloantigens: implications for graft-versus-host disease.
    Yolcu ES, Singh NP.
    Transplant Proc; 2013 Jun 01; 45(5):1850-2. PubMed ID: 23769056
    [Abstract] [Full Text] [Related]

  • 7. Examination of the sensitivity of T cells to Fas ligation: induction of allospecific apoptosis.
    O'Flaherty E, Ali S, Pettit SJ, Kirby JA.
    Transplantation; 1998 Oct 27; 66(8):1067-73. PubMed ID: 9808493
    [Abstract] [Full Text] [Related]

  • 8. Dendritic cells transduced with viral interleukin 10 or Fas ligand: no evidence for induction of allotolerance in vivo.
    Buonocore S, Van Meirvenne S, Demoor FX, Paulart F, Thielemans K, Goldman M, Flamand V.
    Transplantation; 2002 Jan 15; 73(1 Suppl):S27-30. PubMed ID: 11810058
    [Abstract] [Full Text] [Related]

  • 9. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand.
    Suzuki I, Fink PJ.
    J Exp Med; 1998 Jan 05; 187(1):123-8. PubMed ID: 9419218
    [Abstract] [Full Text] [Related]

  • 10. Rhesus monkey immature monocyte-derived dendritic cells generate alloantigen-specific regulatory T cells from circulating CD4+CD127-/lo T cells.
    Zahorchak AF, Raimondi G, Thomson AW.
    Transplantation; 2009 Nov 15; 88(9):1057-64. PubMed ID: 19898200
    [Abstract] [Full Text] [Related]

  • 11. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.
    Min WP, Gorczynski R, Huang XY, Kushida M, Kim P, Obataki M, Lei J, Suri RM, Cattral MS.
    J Immunol; 2000 Jan 01; 164(1):161-7. PubMed ID: 10605007
    [Abstract] [Full Text] [Related]

  • 12. CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling.
    Strauss G, Lindquist JA, Arhel N, Felder E, Karl S, Haas TL, Fulda S, Walczak H, Kirchhoff F, Debatin KM.
    J Exp Med; 2009 Jun 08; 206(6):1379-93. PubMed ID: 19487421
    [Abstract] [Full Text] [Related]

  • 13. Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity.
    Strauss G, Osen W, Knape I, Jacobsen EM, Müller SM, Debatin KM.
    Cell Death Differ; 2007 Mar 08; 14(3):480-8. PubMed ID: 16902496
    [Abstract] [Full Text] [Related]

  • 14. CTLA-4. FasL induces alloantigen-specific hyporesponsiveness.
    Elhalel MD, Huang JH, Schmidt W, Rachmilewitz J, Tykocinski ML.
    J Immunol; 2003 Jun 15; 170(12):5842-50. PubMed ID: 12794109
    [Abstract] [Full Text] [Related]

  • 15. Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death.
    Hartwig UF, Robbers M, Wickenhauser C, Huber C.
    Blood; 2002 Apr 15; 99(8):3041-9. PubMed ID: 11929798
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive properties of CD95L-transduced "killer" hybrids created by fusing donor- and recipient-derived dendritic cells.
    Matsue H, Matsue K, Kusuhara M, Kumamoto T, Okumura K, Yagita H, Takashima A.
    Blood; 2001 Dec 01; 98(12):3465-72. PubMed ID: 11719389
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The CD95/CD95L system as target for modulation of allogeneic immune responses].
    Schwinzer R, Dulat H, Kyas U, Wonigeit K.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Dec 01; 115(Suppl I):655-8. PubMed ID: 14518336
    [Abstract] [Full Text] [Related]

  • 20. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.
    Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW.
    J Immunol; 1997 Jun 15; 158(12):5676-84. PubMed ID: 9190916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.